TrialThe Journal of infectious diseases2008

Valganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial.

Corey Casper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.